Home / Healthcare / CTI BioPharma Corp. (CTIC) Charges Ahead 6.33%, Just After Opening Bell on September 22 to Bolster Health Care Stocks

CTI BioPharma Corp. (CTIC) Charges Ahead 6.33%, Just After Opening Bell on September 22 to Bolster Health Care Stocks

CTI BioPharma Corp. (CTIC) is one of the best performing stocks in the health care sector for companies listed on the New York Stock Exchange or NASDAQ exchange shortly after the opening bell on September 22. Shares of CTIC have climbed 6.33% about 30 minutes into the session to $0.4 after closing the day prior at $0.37. It’s early, but the stock has traded as high as $0.4 and as low as $0.39 so far. Today’s quick advance has come with about 320,030 shares changing hands, compared to an average 30-day volume of 951,040 for CTI BioPharma Corp.. The price is currently below the 30-day volume weighted average price of $0.39 for CTIC.

The share appreciation gives the company a market capitalization of $105.07 million based upon 282.82 million shares outstanding. It also means that CTIC has a price-to-book ratio of 2.5:1 and a price-to-earnings ratio of :1.

In the past 52 weeks, shares of CTIC have traded as low as $0.2514 and as high as $1.75. Technical traders will take note that at $0.4, shares of CTIC are trading below their 200-day MA at $0.6 and above their 50-day MA at $0.36. Technical analysts pay close attention to these key moving averages because they often serve as technical support and resistance levels and because a move through or holding above them is typically regarded as bullish.

Who is CTIC?

CTI Biopharma Corp is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer benefit to patients and health care providers. The company’s 149 employees are led by CEO James A. Bianco from the corporate headquarters at 3101 Western Avenue.

For more information on CTIC and other companies trading on the major exchanges, as well as the over the counter markets, or to be considered for contributing content for our distribution network, visit FinancialPress.com today.

All data provided by QuoteMedia, with stock data accurate as of 9:30 AM ET. FinancialPress.com is not responsible for inaccuracies in third-party supplied information.

About FinancialPress.com

FinancialPress.com is a leading publisher of market and investment news, commentary, proprietary research and videos from seasoned journalists, analysts and contributors covering the financial markets and global economies. Leveraging our extensive distribution network and social media presence, we have cultivated a valuable audience of engaged market enthusiasts, which in turn delivers a variety of unique opportunities for industry partnerships, corporate communications, market exposure and investment. A complete disclaimer can be viewed here.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of FinancialPress.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://financialpress.com/legal-disclaimer/.

Check Also

ONEnergy Inc. (CDX:OEG:CA) Bolsters TSX Venture Utility Stocks, Rising 53.66% at Midday on September 30

ONEnergy Inc. (CDX:OEG:CA) is amongst the strongest stocks in the utilities sector of the TSX …